Brittney Cotta

University of California San Diego

Papers

1

Total Citations

41

H-Index

1

About

Brittney Cotta is a urologic oncologist whose research focuses on the surgical and perioperative management of renal cell carcinoma (RCC), particularly cases involving inferior vena caval (IVC) thrombus. Her most cited work, a 2019 multicenter comparative analysis, demonstrated that neoadjuvant sunitinib therapy can significantly reduce IVC thrombus size and is associated with improved oncologic outcomes in patients with advanced RCC. This study, which has garnered 41 citations, provides critical evidence for integrating targeted therapy before high-risk surgery, offering a potential paradigm shift in managing tumor thrombus. Cotta’s contributions extend to refining surgical techniques and optimizing multimodal treatment strategies for complex urologic cancers. Her research underscores the importance of collaborative, multi-institutional data in advancing personalized care for patients with aggressive renal tumors. By bridging medical oncology and surgical innovation, Cotta’s work has a direct impact on clinical decision-making, helping to improve survival and quality of life for those facing challenging RCC presentations.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: University of California San Diego

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago